The FDA is recruiting new members for its advisory committees — the independent panels that review tobacco products, including nicotine pouches, and advise the agency on everything from product authorizations to public health policy.

The committees bring together scientists, clinicians, and consumer representatives to provide outside perspectives on FDA-regulated products. For nicotine pouches, that could mean input on pending premarket tobacco product applications (PMTAs), flavor restrictions, youth appeal questions, or harm reduction claims.

Why This Matters for Pouches

Advisory committees don't make final decisions, but they shape them. When the FDA faces a contentious call — like whether to authorize a flavored product or how to weigh reduced-risk claims — it can convene a committee to hear the evidence and vote on recommendations.

Nicotine pouches sit at the center of several open questions:

• PMTAs: Thousands of pouch applications are still under review. An advisory committee could be asked to weigh in on whether specific products meet the "appropriate for the protection of public health" standard.
• Youth use: The FDA has flagged flavored products as a youth risk. Committees could review data on pouch appeal to minors.
• Modified risk claims: If a manufacturer applies to market a pouch as lower-risk than cigarettes, an advisory committee would likely review the application.

The committees have historically played a role in high-stakes tobacco decisions, including the denial of flavored e-cigarette PMTAs and the review of heated tobacco products.

Who Gets a Seat

The FDA is looking for:

• Scientific experts: researchers in tobacco control, toxicology, epidemiology, or related fields.
• Consumer representatives: individuals who can speak to the public health impact of tobacco products, including people affected by tobacco use or cessation advocates.

Members serve multi-year terms and meet several times a year, reviewing data, hearing from stakeholders, and voting on recommendations to the FDA.

What Happens Next

The FDA hasn't specified which committees are recruiting or when the new members will be seated. The agency typically announces openings through the Federal Register and accepts nominations on a rolling basis.

For the nicotine pouch industry, the composition of these committees matters. A panel heavy on tobacco control advocates may take a harder line on flavors and youth access. One with more harm reduction researchers could be more open to reduced-risk arguments.

The recruitment itself doesn't signal imminent regulatory action, but it does mean the FDA is restocking the bench — and nicotine pouches are likely to come up.

---

SOURCES:
Tobacco Reporter